Skip to main content
    O

    Oncolytics Biotech Inc (ONCY)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.34
    -0.03 (-8.14%)

    Market Cap: $48.51M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Earnings

    Upcoming Estimates

    Report date not yet scheduledPeriod ending Dec 31, 2026
    EPS Consensus-0.08
    Range-0.08 - -0.08
    2 analysts
    Revenue Consensus
    N/A
    RangeN/A
    2 analysts
    Last 12 of 40 reported quarters and 1 upcoming estimate
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    Date TBD
    --0.08-0.08 - -0.08--2--
    Sep 26
    Reported Nov 13
    -0.08-0.07-0.08 - -0.07--2
    0
    1
    30d
    -
    Jun 26
    Reported Aug 12
    -0.08-0.07-0.08 - -0.07--4
    0
    2
    30d
    -
    Mar 26
    Reported May 14
    -0.11-0.07-0.10 - -0.05--4
    0
    1
    30d
    -
    Dec 25
    Reported Mar 30
    Not reported-0.08-0.12 - -0.07--4
    1
    2
    30d
    -
    Sep 25
    Reported Nov 12
    -0.14-0.07-0.07 - -0.06--4
    3
    0
    30d
    -
    Jun 25
    Reported Aug 8
    -0.07-0.08-0.09 - -0.08--3
    No revisions (30d)
    -
    Mar 25
    Reported May 14
    -0.08-0.09-0.09 - -0.09--2
    No revisions (30d)
    -
    Dec 24
    Reported Mar 7
    -0.10-0.13-0.14 - -0.13--2
    0
    2
    30d
    -
    Sep 24
    Reported Nov 12
    -0.12-0.11N/A--6
    No revisions (30d)
    -
    Jun 24
    Reported Aug 1
    -0.10-0.11N/A--5
    No revisions (30d)
    -
    Mar 24
    Reported May 9
    -0.09-0.11N/A--4
    No revisions (30d)
    -
    Dec 23
    Reported Mar 7
    -0.05-0.15N/A--6
    No revisions (30d)
    -

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-769.00%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio0.89xQuick Ratio0.89x
    Trading Statistics
    Beta1.24Avg Volume991.21K
    52-Week High$1.3052-Week Low$0.34

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 40.1% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 28.1, below 30, the oversold line.

    Moving Averages

    SMA 10$0.40
    SMA 20$0.43
    SMA 50$0.57
    SMA 200$0.82
    EMA 10$0.39
    EMA 20$0.43
    EMA 50$0.54
    EMA 200$0.76

    MACD

    Line: -0.06Signal: -0.06Hist: 0.00

    ADX

    ADX: 41.4+DI: 8.7-DI: 26.5

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down96.0
    PSAR$0.40

    Bollinger Bands

    Upper Band$0.53
    Lower Band$0.33
    %B Position4548%(Upper)
    Band Width0.03

    RSI (14-Day)

    Oversold
    28.1

    Momentum Oscillators

    Stoch %K8.9
    Stoch %D12.5
    Williams %R-97.2
    ROC (10d)-15.0%
    Momentum-0.06
    CCI (20d)-141.1
    MFI (14d)37.5

    Volatility Measures

    ATR (14d)$0.05(13.7%)
    StdDev (20d)0.05
    Hist Vol80.6%(High)

    Volume Flow

    VWAP$0.35
    OBV14.0M
    AD Line-39.3M
    CMF (20d)-0.118

    Volume Metrics

    Avg Vol (20d)1.0M
    Vol Ratio1.3x
    VWMA (20d)$0.43

    Pivot Points

    R3$0.45
    R2$0.42
    R1$0.39
    Pivot Point$0.37
    S1$0.34
    S2$0.31
    S3$0.29

    Advanced Oscillators

    TSI-39.16
    Ultimate Osc38.6
    KST-296.89

    Financial Data

    QuarterSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total Revenue$0$0$0$0$0$0$0CAD 0CAD 0CAD 0CAD 0CAD 0
    Cost of Revenue$0$0$0N/A$0$0$0N/ACAD 72.00KCAD 71.62KCAD 123.00KCAD 107.00K
    Gross Profit$0$0$0N/A$0$0$0N/ACAD -72.00KCAD -71.62KCAD -123.00KCAD -107.00K
    Operating Expenses$9.74M$9.38M$9.28M$2.99M$9.56M$4.65M$5.02MCAD 8.44MCAD 9.90MCAD 5.72MCAD 8.60MCAD 8.74M
    R&D$5.15M$4.26M$4.55M$2.96M$5.08M$1.92M$2.80MCAD 4.55MCAD 6.79MCAD 3.33MCAD 5.74MCAD 4.66M
    SG&A$4.59M$5.12M$4.73M$6.89M$4.48M$2.73M$2.22MCAD 3.46MCAD 3.10MCAD 3.26MCAD 2.86MCAD 4.08M
    Operating Income-$9.74M-$9.38M-$9.28MN/A-$9.56M-$4.65M-$5.02MCAD -8.44MCAD -9.90MCAD -5.79MCAD -8.73MCAD -8.85M
    Interest Income$19.00K$37.00K$44.00K$0$95.00K-$288.00K$117.00KCAD 152.00KCAD 261.00KCAD 340.00KCAD 446.00KCAD 489.00K
    Interest ExpenseN/A$0$0N/A$812.00K$565.00K$0CAD 0CAD 0CAD 0CAD 0CAD 0
    Income Before Tax-$9.72M-$9.34M-$9.24M-$1.73M-$10.06M-$5.22M-$4.71MCAD -7.99MCAD -9.53MCAD -5.23MCAD -6.89MCAD -3.91M
    Income Tax Expense-$13.00K$101.00K$0$337.54K-$181.00K$61.00K$0CAD 23.00KCAD 12.00KCAD 69.43KCAD 79.72KCAD 43.00K
    Net Income-$9.71M-$9.44M-$9.24M-$2.07M-$9.88M-$5.28M-$4.71MCAD -8.02MCAD -9.54MCAD -5.30MCAD -6.89MCAD -3.95M
    EBITDA-$9.72M-$9.36M-$9.27MN/A-$10.14M-$4.91M-$4.81MCAD -8.34MCAD -9.79MCAD -5.16MCAD -8.60MCAD -8.74M
    EBIT-$9.74M-$9.38M-$9.29MN/A-$10.15M-$4.93M-$4.83MCAD -8.44MCAD -9.90MCAD -5.23MCAD -8.73MCAD -8.85M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about ONCY

    News

    ONCY Valuation

    ONCY Profitability: Margins, ROIC and FCF

    Oncolytics Biotech (ONCY) has an operating margin of 0.0% and a net margin of 0.0%.

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -769.0%

    Oncolytics Biotech Competitors

    The companies most similar to Oncolytics Biotech (ONCY) include Cardiff Oncology, OS Therapies and Connect Biopharma Holdings.

    Sector: Healthcare

    Companies most similar to Oncolytics Biotech

    ONCY Analyst Ratings

    Oncolytics Biotech (ONCY) has a Buy consensus from 5 analysts: 4 Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell.

    Consensus
    Buy
    Analysts
    5
    Strong Buy
    2
    Buy
    2
    Hold
    1
    Sell
    0
    Strong Sell
    0

    ONCY Bull Case vs Bear Case

    Bull case

    • 80.0% of ONCY's analyst ratings are Buy or Strong Buy.

    ONCY Earnings Call

    The latest ONCY earnings call transcript on file is labeled 2025Q1.

    Read the 2025Q1 transcript

    Updated Nov 13, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About ONCY

    Does ONCY pay dividends?

    Oncolytics Biotech Inc (ONCY) does not currently pay a regular dividend.

    What is ONCY's market cap?

    Oncolytics Biotech Inc (ONCY) has a market capitalization of $48.51M with a current stock price of $0.34.

    How do analysts rate ONCY stock?

    5 analysts cover Oncolytics Biotech Inc (ONCY): 2 rate it Strong Buy, 2 Buy, 1 Hold, 0 Sell and 0 Strong Sell, a consensus of Buy.

    ONCY pages: Overview, Competitors

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.